IBDEI04J ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1596,1,4,0)
 ;;=4^R25.2
 ;;^UTILITY(U,$J,358.3,1596,2)
 ;;=^5019301
 ;;^UTILITY(U,$J,358.3,1597,0)
 ;;=M88.9^^3^45^53
 ;;^UTILITY(U,$J,358.3,1597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1597,1,3,0)
 ;;=3^Osteitis deformans of unspecified bone
 ;;^UTILITY(U,$J,358.3,1597,1,4,0)
 ;;=4^M88.9
 ;;^UTILITY(U,$J,358.3,1597,2)
 ;;=^5014899
 ;;^UTILITY(U,$J,358.3,1598,0)
 ;;=M81.0^^3^45^6
 ;;^UTILITY(U,$J,358.3,1598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1598,1,3,0)
 ;;=3^Age-related osteoporosis w/o current path fx
 ;;^UTILITY(U,$J,358.3,1598,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,1598,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,1599,0)
 ;;=M80.08XA^^3^45^5
 ;;^UTILITY(U,$J,358.3,1599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1599,1,3,0)
 ;;=3^Age-related osteoporosis w/ current path fx,vertebra,init enctr
 ;;^UTILITY(U,$J,358.3,1599,1,4,0)
 ;;=4^M80.08XA
 ;;^UTILITY(U,$J,358.3,1599,2)
 ;;=^5013495
 ;;^UTILITY(U,$J,358.3,1600,0)
 ;;=M87.00^^3^45^38
 ;;^UTILITY(U,$J,358.3,1600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1600,1,3,0)
 ;;=3^Idiopathic aseptic necrosis of unspecified bone
 ;;^UTILITY(U,$J,358.3,1600,1,4,0)
 ;;=4^M87.00
 ;;^UTILITY(U,$J,358.3,1600,2)
 ;;=^5014657
 ;;^UTILITY(U,$J,358.3,1601,0)
 ;;=M87.051^^3^45^37
 ;;^UTILITY(U,$J,358.3,1601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1601,1,3,0)
 ;;=3^Idiopathic aseptic necrosis of right femur
 ;;^UTILITY(U,$J,358.3,1601,1,4,0)
 ;;=4^M87.051
 ;;^UTILITY(U,$J,358.3,1601,2)
 ;;=^5014680
 ;;^UTILITY(U,$J,358.3,1602,0)
 ;;=M87.052^^3^45^36
 ;;^UTILITY(U,$J,358.3,1602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1602,1,3,0)
 ;;=3^Idiopathic aseptic necrosis of left femur
 ;;^UTILITY(U,$J,358.3,1602,1,4,0)
 ;;=4^M87.052
 ;;^UTILITY(U,$J,358.3,1602,2)
 ;;=^5014681
 ;;^UTILITY(U,$J,358.3,1603,0)
 ;;=M94.0^^3^45^17
 ;;^UTILITY(U,$J,358.3,1603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1603,1,3,0)
 ;;=3^Chondrocostal junction syndrome [Tietze]
 ;;^UTILITY(U,$J,358.3,1603,1,4,0)
 ;;=4^M94.0
 ;;^UTILITY(U,$J,358.3,1603,2)
 ;;=^5015327
 ;;^UTILITY(U,$J,358.3,1604,0)
 ;;=M89.9^^3^45^10
 ;;^UTILITY(U,$J,358.3,1604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1604,1,3,0)
 ;;=3^Bone Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,1604,1,4,0)
 ;;=4^M89.9
 ;;^UTILITY(U,$J,358.3,1604,2)
 ;;=^5015119
 ;;^UTILITY(U,$J,358.3,1605,0)
 ;;=M94.9^^3^45^15
 ;;^UTILITY(U,$J,358.3,1605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1605,1,3,0)
 ;;=3^Cartilage Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,1605,1,4,0)
 ;;=4^M94.9
 ;;^UTILITY(U,$J,358.3,1605,2)
 ;;=^5015366
 ;;^UTILITY(U,$J,358.3,1606,0)
 ;;=M94.20^^3^45^18
 ;;^UTILITY(U,$J,358.3,1606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1606,1,3,0)
 ;;=3^Chondromalacia, unspecified site
 ;;^UTILITY(U,$J,358.3,1606,1,4,0)
 ;;=4^M94.20
 ;;^UTILITY(U,$J,358.3,1606,2)
 ;;=^5015329
 ;;^UTILITY(U,$J,358.3,1607,0)
 ;;=R70.0^^3^45^26
 ;;^UTILITY(U,$J,358.3,1607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1607,1,3,0)
 ;;=3^Elevated erythrocyte sedimentation rate
 ;;^UTILITY(U,$J,358.3,1607,1,4,0)
 ;;=4^R70.0
 ;;^UTILITY(U,$J,358.3,1607,2)
 ;;=^5019559
 ;;^UTILITY(U,$J,358.3,1608,0)
 ;;=S12.9XXA^^3^45^31
 ;;^UTILITY(U,$J,358.3,1608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1608,1,3,0)
 ;;=3^Fx of Neck,Unspec,Init Encntr
 ;;^UTILITY(U,$J,358.3,1608,1,4,0)
 ;;=4^S12.9XXA
 ;;^UTILITY(U,$J,358.3,1608,2)
 ;;=^5021962
 ;;^UTILITY(U,$J,358.3,1609,0)
 ;;=S22.009A^^3^45^33
 ;;^UTILITY(U,$J,358.3,1609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1609,1,3,0)
 ;;=3^Fx of Thoracic Vertebra,Unspec,Init for Closed Fx
 ;;
 ;;$END ROU IBDEI04J
